John Goertz net worth
Quick answer
John Goertz's estimated net worth is $35.0M (range $24.5M – $52.5M) as of 2026. John Goertz is Founder at Signatur Biosciences. Signatur Biosciences valuation.
John Goertz is Founder at Signatur Biosciences (YC S22). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: Stanford University
- Region: United States of America
- Industries: Healthcare, Diagnostics
- Team size: 5
- Website: https://www.signatur.bio/
Who is John Goertz?
John Goertz is one of the founders of Signatur Biosciences, a startup participating in Y Combinator's Summer 2022 batch.
Highlights:
- Stanford University
- Y Combinator (S22)
- Signatur Biosciences
About Signatur Biosciences
We make precision diagnostics more accessible, starting with breast cancer prognosis. Current tests that guide the use of therapy are really slow and expensive because they need to be run in complex centralized facilities. Our tests are designed to be easily run by local hospital labs, reducing turnaround time from over three weeks to a few days and for a fraction of the price.
FAQ: John Goertz net worth and Signatur Biosciences valuation
What is John Goertz's net worth?
John Goertz's estimated net worth is $35.0M (range $24.5M – $52.5M) as of 2026. John Goertz is Founder at Signatur Biosciences. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Signatur Biosciences valuation?
Signatur Biosciences's estimated valuation on Entrepreneurial Check is $70.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is John Goertz's role?
John Goertz is Founder at Signatur Biosciences, a Y Combinator-backed startup (batch S22).